Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global OTC Artificial Tear Market



6. Market Share
6.1 By Product Type
6.2 By Application
6.3 By Distribution Channel
6.4 By Country


7. Product Type
7.1 Solution
7.2 Ointment
7.3 Emulsion
7.4 Gel
7.5 Spray Solution
7.6 Suspensions


8. Application
8.1 Dry Eye Syndrome
8.2 Allergies
8.3 Infections
8.4 UV and Blue Light Protection
8.5 Contact Lens Moisture Retention
8.6 Others


9. Distribution Channel
9.1 Drugstores & Supermarkets
9.2 Online Pharmacies
9.3 Retail Pharmacies
9.4 Others


10. Country
10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players
13.1 AbbVie Inc.
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 Akorn Inc.
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Alcon
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue

13.4 Bausch Health Companies Inc.
13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 Johnson & Johnson
13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue

13.6 Nicox S.A.
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue

13.7 Novartis AG
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue

13.8 Santen Pharmaceutical Co. Ltd.
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue

13.9 Sun Pharmaceutical Industries Ltd.
13.9.1 Overview
13.9.2 Recent Development
13.9.3 Revenue



List of Figures

0

List of Tables

0